Rosa Rebollar‐Vega

Author

Rosa Rebollar‐Vega

National Institute of Genomic Medicine ORCID

Also Known As

R. Rebollar-Vega, Rosa G Rebollar-Vega, Rosa G. Rebollar-Vega, Rosa Gloria Rebollar-Vega, Rosa Rebollar Vega, Rosa Rebollar-Vega, Rosa Rebollar‐Vega

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

National Institute of Genomic Medicine Universidad Nacional Autónoma de México Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Instituto Nacional de Cancerología Instituto Nacional de Enfermedades Respiratorias

About

Rosa Rebollar‐Vega is an author at National Institute of Genomic Medicine specializing in medicine, systems biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	1.3K
2	Engineering	2	2	1.2K
3	Cell Biology	2	2	79
4	Biology	1	1	15
5	Microbiology	1	1	15

Rosa Rebollar‐Vega

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Sequence analysis of mutations and translocations across breast cancer subtypes Shantanu Banerji, Kristian Cibulskis, Claudia Rangel‐Escareño, Nature Recurrent MutationsBreast OncologyOncologyEngineeringSomatic Variant	2012	1.2K
Comprehensive omic characterization of breast cancer in Mexican-Hispanic women Sandra Romero‐Córdoba, Iván Salido-Guadarrama, Rosa Rebollar‐Vega, Nature Communications	2021	290
Identification and Pathway Analysis of microRNAs with No Previous Involvement in Breast Cancer Sandra Romero‐Córdoba, Sergio Rodrı́guez-Cuevas, Rosa Rebollar‐Vega, PLoS ONE Radiation OncologyPrevious InvolvementMicrorna Expression SignaturesEngineeringBreast Oncology	2012	49
A lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtype Alberto Cedro‐Tanda, M. Rios-Romero, Sandra Romero‐Córdoba, Scientific Reports	2020	33
Expression of long non‐coding <scp>RNA ENSG</scp>00000226738 (Lnc<scp>KLHDC</scp>7B) is enriched in the immunomodulatory triple‐negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death Fredy Omar Beltrán‐Anaya, Sandra Romero‐Córdoba, Rosa Rebollar‐Vega, Molecular Oncology Tumor BiologyTranscriptional RegulationAlteration PromotesMedicineCancer Cell Biology	2019	30
Population and breast cancer patients’ analysis reveals the diversity of genomic variation of the BRCA genes in the Mexican population Juan Carlos Fernández-López, Sandra Romero‐Córdoba, Rosa Rebollar‐Vega, Human Genomics	2019	24
Increased dietary protein stimulates amino acid catabolism via the gut microbiota and secondary bile acid production Sandra Tobón‐Cornejo, Mónica Sánchez‐Tapia, Rocío Guizar-Heredia, Gut Microbes	2025	20
Transcriptome Analysis Identifies GATA3-AS1 as a Long Noncoding RNA Associated with Resistance to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients Laura Contreras‐Espinosa, Nicolás Alcaraz, Inti A. De La Rosa-Velázquez, Journal of Molecular Diagnostics	2021	19
Genotoxicity studies of organically grown broccoli (Brassica oleracea var. italica) and its interactions with urethane, methyl methanesulfonate and 4-nitroquinoline-1-oxide genotoxicity in the wing spot test of Drosophila melanogaster María Eugenia Heres-Pulido, Irma Elena Dueñas-García, Laura Castañeda-Partida, Food and Chemical Toxicology BiologyDrosophila MelanogasterPhytotoxicityPesticide ResistancePest Management	2009	15
Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease Rosa Rebollar‐Vega, Julia M. Zuarth-Vázquez, Laura C. Hernández‐Ramírez Archives of Medical Research	2023	13

Page 1